{"disease":{"id":"maintenance-treatment-of-diffuse-midline-gliomas-in-children","name":"maintenance treatment of diffuse midline gliomas in children"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07020052","title":"Phase II Exploratory Study of Sequential Triple Therapy (Temozolomide/Anlotinib/Bemarituzumab) in Combination With Concurrent Radiotherapy With Temozolomide and Anlotinib for the Maintenance Treatment of Diffuse Midline Gliomas in Children","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":33,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}